New York, NY -- (SBWIRE) -- 11/14/2013 -- StockMarketIntel.com issues a special report on the following stocks: AMERICAN COMMUNITY (OTCMKTS:ACYD), Rite Aid Corporation (NYSE:RAD), Arch Coal Inc (NYSE:ACI), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)
AMERICAN COMMUNITY (OTCMKTS:ACYD) added 9.76%, trading on 8.45 million shares, to end the trade at $0.0450. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.0005 and was moved to the maximum level of $0.0819. The stock changed hands in a range of $0.03 to $0.05, bringing its market capitalization to about $103.87 million.
Will ACYD Continue To Move Higher? Find Out Here
Rite Aid Corporation (NYSE:RAD) added 0.77%, to complete the trading session at $5.26, with a total volume of 13.78 million shares. The stock, on average, trades on a volume of 27.11 million shares. In the past 52 weeks, the share price has not declined below $0.95 and above $5.44. It floated in a range of $5.18 to $5.28 during the last trading session, with a beta value of 2.27. Its market capitalization now moved to about $4.82 billion. Rite Aid Corporation is a retail drugstore chain in the United States. As of March 3, 2013, it operated 4,623 stores in 31 states across the country and in the District of Columbia. In the Company’s stores, it sells prescription drugs and a range of other merchandise, which it calls front end products. During the fiscal year ended March 3, 2013 (fiscal 2013), prescription drug sales accounted for 67.6% of its total sales.
Why Should Investors Buy RAD After The Recent Gain? Just Go Here and Find Out
Arch Coal Inc (NYSE:ACI) added 0.70% and was in a range of $4.18-$4.30 before closing at $4.30. The share price hit its 52-week low of $3.47 and $7.95 was the best price. The stock completed the day with a total volume of 7.65 million shares, versus an average volume of 9.58 million shares. Arch Coal, Inc. (Arch) is the coal producer. The Company sells substantially all of its coal to power plants, steel mills and industrial facilities. As of December 31, 2012, it operated, or contracted out the operation of, 32 active mines located in each of the coal-producing regions of the United States. The locations of its mines and access to export facilities enable them to ship coal worldwide.
What was the Moving Force behind ACI on Bullish Run? Read This Research Report
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) declined -3.58%, bringing its market capitalization around $259.97 million. The total number of shares that changed hands during the session was 2.96 million shares, as compared to average trading volume of 2.88 million shares. The share price, after opening at $2.78, made a high of $2.85 and hovered above $2.62 to end the day at $2.69. Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the treatment of resistant bacterial infections.
Is it the Right to Grab ACHN after the Recent Slump? Get Free Trend Analysis Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)